Revolutionary Immunotherapy Offers Hope for Reversing Alzheimer's
Researchers at the University of Colorado Alzheimer's and Cognition Center have discovered that a drug called GM-CSF, already approved for rheumatoid arthritis, can reverse Alzheimer's disease. In addition, two commonly used psychiatric drugs, imipramine and olanzapine, were found to block the effects of a protein known as APOE4, which significantly increases the risk of developing Alzheimer's. These findings offer hope for more personalized care and the development of effective treatments for Alzheimer's patients.